Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Management of Upper Gastrointestinal Bleeding in Patients Taking Nimesulide

Immediate Resuscitation and Initial Management

  • The American College of Physicians recommends initiating fluid resuscitation with crystalloids in patients with hemodynamic instability to restore end-organ perfusion 4, 5
  • The American College of Gastroenterology recommends transfusing blood if hemoglobin is low in patients without cardiovascular disease; use a higher threshold for those with cardiovascular disease 2, 3, 6
  • The American Gastroenterological Association recommends discontinuing nimesulide immediately as NSAIDs are a major cause of peptic ulcer bleeding and continuing therapy increases rebleeding risk 7, 8, 9

Risk Stratification

  • The American College of Gastroenterology recommends using the Glasgow Blatchford score to identify very low-risk patients who may not require hospitalization or inpatient endoscopy 2, 3
  • The American Gastroenterological Association considers nasogastric tube placement in selected patients as findings have prognostic value, with bright blood being an independent predictor of rebleeding 2, 5

Pharmacologic Management

  • The American College of Physicians recommends starting intravenous PPI therapy immediately upon presentation, before endoscopy 1, 4, 5
  • The American College of Gastroenterology recommends pre-endoscopic PPI therapy to downstage the lesion and decrease the need for endoscopic intervention but should not delay endoscopy 2, 3
  • The American Gastroenterological Association recommends using PPI via intravenous loading dose followed by continuous infusion for 3 days after successful endoscopic hemostasis for high-risk stigmata (strong recommendation, moderate-quality evidence) 1, 10

Endoscopic Management

  • The American College of Gastroenterology recommends performing endoscopy within 24 hours of presentation 2, 3, 4
  • The American Gastroenterological Association recommends endoscopic hemostasis for high-risk stigmata (active bleeding or visible vessel in ulcer bed) 2, 3, 6
  • The American College of Physicians recommends using combination therapy: thermocoagulation or sclerosant injection with clips (strong recommendation) 3, 6

Post-Endoscopic Care

  • The American College of Physicians recommends hospitalizing high-risk patients for at least 72 hours after endoscopic hemostasis 1, 10, 4
  • The American Gastroenterological Association recommends testing all patients for Helicobacter pylori and providing eradication therapy if present, with confirmation of eradication 1, 10

Secondary Prevention After NSAID-Induced Bleeding

  • The American College of Gastroenterology recommends that if NSAID is absolutely required, recognizing that traditional NSAID plus PPI OR COX-2 inhibitor alone still carries clinically important rebleeding risk 1, 10
  • The American Gastroenterological Association recommends the combination of PPI plus COX-2 inhibitor to reduce recurrent bleeding risk beyond COX-2 inhibitor alone 1, 10
  • The American College of Physicians recommends avoiding nimesulide and other NSAIDs if possible in patients with a history of ulcer complications (very high-risk category) 9

REFERENCES

1

Management of Upper GI Bleeding [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Upper Gastrointestinal Bleeding [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025